Literature DB >> 7479564

Analysis of diclofenac and four of its metabolites in human urine by HPLC.

R J Sawchuk1, J A Maloney, L L Cartier, R J Rackley, K K Chan, H S Lau.   

Abstract

An HPLC method for the determination of diclofenac (DCF) and four of its metabolites (3'-hydroxydiclofenac, 4'-hydroxydiclofenac, 5-hydroxydiclofenac, and 3'-hydroxy-4'-methoxydiclofenac) in human urine is described. Following base hydrolysis, the samples were neutralized and extracted. Evaporated extracts were reconstituted in mobile phase containing ascorbic acid, and chromatographed, using flow-rate programming, on a reversed-phase column. Absolute recovery (average), was at least 78% for diclofenac and ranged from 75 to 85% for the four metabolites. Standard curves showed linearity over the range of concentrations of 0.2 to 40 ug/mL, using 0.25 mL of urine. Specificity was demonstrated by examining chromatograms of extracts of blank urine from 8 volunteers and 24 study subjects. Good accuracy was observed for all compounds over the concentration range of 0.2 to 40 ug/mL using 0.25 mL of urine. Based on accuracy and precision criteria, the limit of quantitation for all 5 analytes was 0.4 ug/mL, using 0.25 mL of urine. Analysis of urine from subjects with normal and reduced renal function who received diclofenac orally demonstrated that total diclofenac and metabolites excreted in the urine represented approximately 31% and 4% of an oral dose of diclofenac, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479564     DOI: 10.1023/a:1016276012891

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.

Authors:  J Godbillon; S Gauron; J P Metayer
Journal:  J Chromatogr       Date:  1985-02-27

2.  Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites.

Authors:  H Stierlin; J W Faigle; A Sallmann; W Küng; W J Richter; H P Kriemler; K O Alt; T Winkler
Journal:  Xenobiotica       Date:  1979-10       Impact factor: 1.908

3.  Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.

Authors:  P H Degen; W Dieterle; W Schneider; W Theobald; U Sinterhauf
Journal:  Xenobiotica       Date:  1988-12       Impact factor: 1.908

4.  Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection.

Authors:  W Schneider; P H Degen
Journal:  J Chromatogr       Date:  1981-11-06
  4 in total
  1 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.